Stella Pharma Corporation , Mitsubishi Chemical Corporation of the Mitsubishi Chemical Group , and the University of Tokyo have concluded an agreement on joint research into the composition of and formulation method for a boron neutron capture therapy (BNCT) drug consisting of polyvinyl alcohol and p-boronophenylalanine with a view to practical applications.
Stella Pharma, Mitsubishi Chemical Group, and the University of Tokyo conclude Joint Research Agreement—Accelerating practical application of polyvinyl alcohol (PVA) for boron neutron capture therapy (BNCT)—
